No title
Introduction: There is a shortcoming in current breast cancer treatment, where some patients get overtreated leading to unnecessary side effects and others will not respond to the indicated treatment. Immune infiltration appears to have potential to become an important parameter when predicting how the tumour will respond to certain treatments, prognosing the survival rates in different subgroups
